ISDA

Deposition Date 2020-03-20

Release Date 2020-04-08

Last Version Date 2024-11-20

Entry Detail

PDB ID:

6W8L

Keywords:

TRANSFERASE/INHIBITOR

Title:

Crystal structure of JAK1 kinase with compound 10

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.11 Å

R-Value Free:

0.22

R-Value Work:

0.19

R-Value Observed:

0.19

Space Group:

C 2 2 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Tyrosine-protein kinase JAK1
Gene (Uniprot):JAK1
Chain IDs:A
Chain Length:316
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P23458 Pfam ID:PF07714 EC:2.7.10.2

Modified Residue

Compound ID	Chain ID	Parent Comp ID	Details	2D Image
PTR	A	TYR	modified residue

Ligand Molecules

R4S

Primary Citation

Design and optimization of a series of 4-(3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-2-amines: Dual inhibitors of TYK2 and JAK1.

Fensome, A, Ambler, C.M, Arnold, E, Banker, M.E, Clark, J.D, Dowty, M.E, Efremov, I.V, Flick, A, Gerstenberger, B.S, Gifford, R.S, Gopalsamy, A, Hegen, M, Jussif, J, Limburg, D.C, Lin, T.H, Pierce, B.S, Sharma, R, Trujillo, J.I, Vajdos, F.F, Vincent, F, Wan, Z.K, Xing, L, Yang, X, Yang, X.Show

Bioorg.Med.Chem. 28 115481 115481 (2020)

PMID: 32253095 DOI: 10.1016/j.bmc.2020.115481

Abstact

Herein, we disclose a new series of TYK2/ JAK1 inhibitors based upon a 3.1.0 azabicyclic substituted pyrimidine scaffold. We illustrate the use of structure-based drug design for the initial design and subsequent optimization of this series of compounds. One advanced example 19 met program objectives for potency, selectivity and ADME, and demonstrated oral activity in the adjuvant-induced arthritis rat model.

Legend

Protein

Chemical

Disease

Primary Citation of related structures